“…All 26 case studies [ 3 , 10 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ] included in the final analysis were non comparative case series with level 3 evidence. In nine comparative studies [ 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 ], outcomes of RASP were compared to outcomes of other minimally invasive modalities (OSP, HoLEP, ThuVEP) for the treatment of benign prostate hyperplasia (BPH).…”